Retrospective chart review study of cefiderocol real world outcomes and safety in the treatment of patients with Gram-negative bacterial infections (GNBI) in the US and Europe (PROVE) First published 12/04/2021 Last updated 23/04/2024 EU PAS number:EUPAS40551 Study Ongoing